← Leaderboards
Karl Ried
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Treatment Response”
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$249,783,490
- David Heimbrook · Leidos Biomedical Research, Inc.$226,464,484
- Jeffrey P Krischer · University Of South Florida$179,054,592
- Lawrence Corey · Fred Hutchinson Cancer Center$168,164,123
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
Research focus
Treatment ResponseGenesTumorGenomicsBaseGene ExpressionCarcinomaDiagnosisColorectalChromosomal InstabilityGenomeEvidence BaseFluorouracilBiopsyCervix CarcinomaCell LineCell NucleusCellsCancer CellAneuploidyBiologicalCollaborationsChemoradiationData Set
Grant awards (12)
Global consequences of aneuploidy on gene expression and nuclear architecture$960,545
ZIA · FY2020 · CA · contact PI
Intratumor heterogeneity and tumor evolution$960,545
ZIA · FY2020 · CA · contact PI
Disease prognostication and treatment response in rectal cancer patients$823,324
ZIA · FY2020 · CA · contact PI
Global consequences of aneuploidy on gene expression and nuclear architecture$1,030,013
ZIA · FY2019 · CA · contact PI
Intratumor heterogeneity and tumor evolution$1,030,013
ZIA · FY2019 · CA · contact PI
Disease prognostication and treatment response in rectal cancer patients$882,867
ZIA · FY2019 · CA · contact PI
Global consequences of aneuploidy on gene expression and nuclear architecture$954,237
ZIA · FY2018 · CA · contact PI
Intratumor heterogeneity and tumor evolution$954,237
ZIA · FY2018 · CA · contact PI
Disease prognostication and treatment response in rectal cancer patients$817,917
ZIA · FY2018 · CA · contact PI
Global consequences of aneuploidy on gene expression and nuclear architecture$1,004,995
ZIA · FY2017 · CA · contact PI
Intratumor heterogeneity and tumor evolution$1,004,995
ZIA · FY2017 · CA · contact PI
Disease prognostication and treatment response in rectal cancer patients$861,424
ZIA · FY2017 · CA · contact PI